Philadelphia, United States
Vitara Biomedical, founded in 2019, is at the forefront of transforming the standard of care for extremely premature newborns. The company is driven by a clear mission, encapsulated in its slogan, "Because every day counts." By focusing on the Care Economy, Health Care, and Medical Devices industries, Vitara Biomedical aims to offer these vulnerable patients and their families expanded lifetime possibilities.
Headquartered in the United States, the company has attracted significant attention from high-profile investors. In its last funding round, a $75.00M Series B investment secured on 13 September 2022, investment participants included prominent names such as GV, Khosla Ventures, Sands Capital Ventures, First Spark Ventures, Fry’s Path Capital, The Children's Hospital of Philadelphia, Martin Varsavsky, and Flerie Invest. This strong backing signals confidence in the company's potential to revolutionize neonatal care with innovative medical solutions.
